Information Library
Results for: High-quality studies - North and Central America
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
Hear from the Experts — December 6, 2011
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Partnering is Key to Maximizing Rewards in Emerging Markets
Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.
-
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
-
Dr. Frank Massam
Hear from the Experts — May 13, 2011
Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd. -
Competitive Edge - Ulcerative Colitis
Case Study — February 2, 2011
Although faced with the challenge of recruiting for this small patient population, enrollment was completed two months ahead of schedule. -
The Patient is Waiting - Quality's Quiet Impact on the Public Trust - Risky Business, Chapter 8
Hear from the Experts — February 2, 2011
Chapter Excerpt from Risky Business: Managing the Quality of America’s Medicines Chapter eight carefully steps into the controversies surrounding the public’s expectations about the affordability, effectiveness and safety of prescription drugs. -
25 Years of Regulation - and Still Failing - Risky Business, Chapter 4
Hear from the Experts — February 2, 2011
Chapter Excerpt from Risky Business: Managing the Quality of America’s Medicines Chapter four identifies two simple principles needed for the improvement of quality management in pharmaceuticals today: managing consistency and maintaining responsiveness. -
Pharmaceutical Quality Control - Taking Comfort in Numbers - Risky Business, Chapter 3
Hear from the Experts — February 2, 2011
Chapter Three Excerpt from Risky Business: Managing the Quality of America’s Medicines by Robert A. Rhoades -
Strange Bedfellows - Science, Business, Politics, and the Law - Risky Business, Chapter 2
Hear from the Experts — February 2, 2011
Chapter Two Excerpt from Risky Business: Managing the Quality of America’s Medicines by Robert A. Rhoades -
H1N1 - Proactive Engagement
Case Study — February 1, 2011
Despite short timelines and government requirements, an H1N1 vaccine study finished in time for the influenza season.
